Immunome Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	587	457	27	157	102	-	-
Market Cap Growth	-	1605.70%	-82.91%	53.68%	-	-	-
Enterprise Value	448	319	6	107	63	-2	-1
PE Ratio	-4.28	-4.28	-0.71	-6.35	-5.72	-	-
PS Ratio	41.85	32.62	-	-	-	-	-
PB Ratio	4.89	3.81	1.61	3.26	2.47	-	-
P/FCF Ratio	-54.44	-54.44	-0.93	-8.57	-8.02	-	-
P/OCF Ratio	-60.41	-60.41	-0.93	-8.60	-8.41	-	-
EV/Sales Ratio	31.99	22.75	-	-	-	-	-
EV/EBITDA Ratio	-3.01	-3.01	-0.18	-4.49	-3.68	0.21	0.07
EV/EBIT Ratio	-2.99	-2.99	-0.17	-4.35	-3.53	0.20	0.07
EV/FCF Ratio	-37.98	-37.98	-0.22	-5.87	-4.94	0.21	0.07
Debt / Equity Ratio	-	-	-	-	0.01	-0.02	-0.05
Debt / EBITDA Ratio	-	-	-	-	-0.04	-0.06	-0.16
Debt / FCF Ratio	-	-	-	-	-0.05	-0.06	-0.15
Quick Ratio	6.33	6.33	2.79	5.07	13.12	1.59	1.09
Current Ratio	6.63	6.63	3.09	5.82	14.12	1.88	1.35
Asset Turnover	0.17	0.17	0	0	0	0	-
Interest Coverage	-	-	-	-2470.10	-468.39	-107.79	-75.91
Return on Equity (ROE)	-286.40%	-286.40%	-139.10%	-49.10%	-624.20%	34.30%	-
Return on Assets (ROA)	-129.00%	-129.00%	-106.20%	-43.50%	-71.90%	-219.70%	-
Return on Capital (ROIC)	-91.36%	-91.36%	-221.59%	-52.31%	-29.22%	29.51%	32.22%
Earnings Yield	-18.21%	-23.36%	-139.97%	-15.76%	-17.48%	-	-
FCF Yield	-1.43%	-1.84%	-107.96%	-11.67%	-12.47%	-	-
Buyback Yield / Dilution	-63.64%	-63.64%	-5.10%	-240.41%	-209.85%	83.22%	-
Total Shareholder Return	-63.64%	-63.64%	-5.10%	-240.41%	-209.85%	83.22%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).